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Multiphoton microfabrication of conducting polymer-
based biomaterials
John. G. Hardy,abc† Derek Hernandez,d† Damian M. Cummings,c Frances A.
Edwards,c* Jason B. Sheard* and Christine E. Schmidtab*
We report the application of multiphoton microfabrication to
prepare conducting polymer (CP)-based biomaterials that
were capable of drug delivery and interacting with brain
tissue ex vivo, thereby highlighting the potential of
multiphoton lithography to prepare electroactive
biomaterials which may function as implantable neural
biointerfaces (e.g. electrodes).
Electrical fields are known to interact with biological tissues
(including cardiac, muscle, nerve and skin tissues), and have
been shown to play roles in a variety of biological processes (e.g.
cell signalling).1,2 Electroactive biomaterials capable of acting as
electrical interfaces with the body (including cardiac pacemakers
and electrodes for stimulation of the brain) have been approved
for clinical application.3-7
The tuneable properties of CPs (e.g. derivatives of polyaniline,
polypyrrole, polythiophene) make them attractive components of
electroactive biomaterials for drug delivery devices, electrodes or
tissue scaffolds.8-19 CPs have been processed into a variety of
materials morphologies including films (via
electropolymerization,20 vapour deposition,21 solution casting,22
spin coating23 or dip coating24), fibers (via electrospinning25 or
wet spinning26), foams (via sacrificial templating27) and hydrogels
(by crosslinking solutions28). While such approaches are effective
routes to functional electroactive materials, the ability to prepare
biomaterials with de-novo designed architectures,29 particularly
CP-based materials30--32 is highly appealing for biomedical
applications because the material must interface with biological
tissues which tend to be topologically complex and feature
anisotropic and asymmetric features.
Researchers have demonstrated it is possible to print CP-based
materials using screen printing,30 rotary printing30 (potentially in a
roll-to-roll fashion), inkjet printing (potentially in 3D)30 and nozzle
extrusion,30 as described in detail in an insightful review from
Wallace and co-workers. 30
Multiphoton fabrication is an approach that potentially allows the
fabrication of de-novo designed architectures with features on
biologically relevant length scales (i.e. µm-scale), and, has
previously been used to manufacture biodegradable biopolymer-
based biomaterials with well-defined topographies capable of
interacting with both bacterial and mammalian cells.33-36 It is
possible to render polymer structures fabricated via multiphoton
lithography electroactive through the growth of a sample
spanning network of metal nanoparticles within the polymer
matrix,37 or by fabricating electroactive polymer-based structures
(e.g. polypyrrole) using the requisite lasers to initiate
polymerization of the monomer and prepare 3D structures
supported on glass or in Nafion® sheets. 38-40
With a view to the preparation of functional 3D CP-based
biomaterials we used multiphoton lithography to fabricate arrays
of polypyrrole wires. The arrays were capable of electrically-
triggered drug delivery from drug loaded wires in vitro and of
interfacing with a slice of mouse brain ex vivo.
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Fig. 1 Camphorsulfonic acid (CSA), carboxyfluorescein (Fluor
CO2H), and tetrodotoxin (TTX).
Fig. 2 A) Optical microscope image of black polypyrrole wires. The dotted white
outline represents the scan area for AFM images, and the white scale bar
represents 10 μm. B) AFM image of wires in dry (top) and hydrated (bottom)
states. C) FTIR spectrum of CSA-doped polypyrrole.
Arrays of polypyrrole wires were fabricated between
contacts on glass via multiphoton lithography (an example of the
wire fabrication process is shown in a video in the supplementary
information). A titanium-doped sapphire laser with
of 740 nm and beam diameter of 1 µm was used to initiate the
polymerization of pyrrole (100 µL) in chloroform
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a wavelength
(900 µL),
enabling the fabrication of polypyrrole wires
Once the fabrication process was complete, the substrate
washed with ethanol to remove traces of pyrrole and dried under
high vacuum. The polypyrrole could be
camphorsulfonic acid (CSA, Fig. 1) during pol
CSA:pyrrole molar ratio of 1:4, followed by washing with
and vacuum drying. Alternatively, the polypyrrole could be doped
post-polymerization by reduction of the polypyrrole with sodium
borohydride,41 immersion in a solution of carboxyfluorescein
(Fluor-CO2H, Fig. 1) in hexafluoroisopropanol
oxidation during air drying, rinsing with water and
Images of the wires obtained via atomic force microscopy (Fig.
2B) suggest their widths are approximately
thicknesses are approximately 0.1 µm in the dry state (confirmed
by SEM, Fig. S1) which swell to thicknesses of
µm when hydrated in phosphate buffered saline (PBS.
dispersive X-ray spectroscopy maps confirm the polypyrrole
wires to be carbon-rich (Fig. S1). Analysis
analogously synthesized polypyrrole with Fourier transform
infrared (FTIR) spectroscopy recorded in attenuated total
reflectance (ATR) mode (Fig. 2C) showed characteristic
vibrational bands associated with C-C and C
1527 and 1423 cm-1, respectively. The band at 12
attributed to C-H or C-N in-plane deformation
1154 and 1029 cm-1 are attributed to C
shoulder at 1714 cm-1 indicates partial overoxidation during the
polymerization process.
The conductance of the polypyrrole wires w
accordance with protocol IPC-TM-650, number 2.5.17.2
described by the Institute for Interconnecting an
Electronic Circuits. We found that the CSA
wires had conductivities of 3.4 (± 0.8) x 10
similar to that reported in the literature
polypyrrole.42
We studied the capability of the polypyrrole wires to deliver a
model drug (carboxyfluorescein, Fig. 1) into PBS. T
stimulation paradigm for electrically-triggered delivery was
simple potential step of 0.6 V applied for 30 seconds across the
array of wires (Figure 3A). Data is presented as ng re
arrays of 30 wires because of the difficulties a
precisely determining the loading efficiency of such
quantities of drug (ng regime), and the
borohydride-mediated degradation of polypyrrole
release of drug (a common problem for most drug delivery
systems) from the unstimulated polypyrrole matrix was observed
(Figure 3B), which is likely to be poorly entrapped drug because
of inefficiencies in the loading process which is not as simple as
for our previously reported solution processable degradable
electroactive polymers.22 Electrical stimulation of the wires
initiates ion transport within the polymer matrix and
oxidation state and conformation of the polypyrrole,
enhancing carboxyfluorescein release
unstimulated control with approximately double the quantity
released during the short experiment (Fig.
release is notable, and the quantity of drug released
electrical stimulation is low (ng regime), it should be possible to
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address this by printing structures with different dimensions
(particularly surface area to volume ratio), and investigating
alternative doping methodologies; nevertheless,
highlight the potential of such multiphoton fabricated
deliver small molecules or drugs (e.g. anti-inflammatories)
the application of an electrical stimulus.
To demonstrate that de novo designed CP-based materials
produced via multiphoton lithography have the potential for future
development as implantable neural interfaces, we used arrays of
polypyrrole wires as an electrode to interact with a slice of mouse
brain ex vivo. The arrays were positioned to stimulate the
Schaffer collaterals in the stratum radiatum and a recording
electrode was positioned in the CA1 region of the
radiatum to record from CA3-CA1 synapses. A potential step of 2
V was applied for 100 µs, and a corresponding response was
recorded by the electrode in the CA1 region (Fig. 3B
This result indicates that the CP-based materials interact
nervous system. The addition of the sodium channel inhibitor
tetrodotoxin (TTX, Figure 1, 1 µM) to the medium resulted in the
disappearance of the axon volley after stimulation
line), thereby confirming that, while we could not dis
postsynaptic response, the response recorded was indeed
physiological, and caused by the firing of action potentials in
response to stimulation provided by the polypyrrole wires.
Fig. 3 A and B) Electrically-triggered “drug” delivery. A) Electrical stimulation
paradigm, rest 30 seconds, application of a potential step of 0.6 V for 30
J. Name
our results
structures to
upon
stratum
, black line).
with the
(Fig. 3B, grey
cern a
seconds, rest for 240 seconds. B) Electrically-triggered delivery
quantified by fluorimetry. Grey circles represent unstimulated control samp
black circles represent electrically stimulated samples
standard deviation (n=5). B) Electrical stimulation of a slice of mouse brain in the
absence (black line) or presence of tetrodotoxin (TTX, grey line). Stimulation
paradigm: application of a potential step of 2 V for 100
The electrochemical stability of the polypyrrole
preserved to acceptable levels over the course of the
experiments (Fig. S3), yet it is known to decrease over long
periods of time.45 Other CPs46
ethylenedioxythiophene) have been demonstrated to have
improved electrochemical stabilities over analogous time
periods,45 and it is noteworthy that arrays of poly(3,4
ethylenedioxythiophene) can also be fabricated using
multiphoton lithography (Fig S4). Preclinical trials have shown
CPs such as polypyrrole to be relatively non
histological analyses revealing no significant inflammation in the
vicinity of polypyrrole-based electrodes implanted in
Dawley rat brains after 3 or 6 weeks.47 By comparison the results
reported for poly(3,4-ethylenedioxythiophene)
electrodes in rats have been somewhat mixed with
and coworkers reporting modest levels of
of approximately the same magnitude as for silicon probes
6 weeks,48 whereas Malliaras and coworkers
levels of tissue reaction than for silicon probes after 4 weeks
however, these conflicting results are likely to be
differences in the dopant anions (perchlorate or
polystyrenesulfonate, respectively), the mechanical properties
between the underlying substrates (iridium or parylene,
respectively), or indeed differences in species of rats used in the
studies (Sprague-Dawley or Wistar, respectiv
these issues would need to be addressed before clinical
translation is possible.
Conclusions
Herein we report the preparation of electroactive polymer (C
based biomaterials via multiphoton lithography. Polypyrrole
based biomaterials were synthesized in one step from
commercially available starting materials.
properties of the polypyrrole wires were characterized.
of the polypyrrole-based materials to deliver small quantities of a
model drug (carboxyfluorescein) was demonstrated
was their ability to interact with a slice of mouse brain
on the application of an electrochemical stimulus
based materials have prospects for the development of
designed implantable electrodes for interaction with the nervous
system, either when inserted in the central nervous system as
highlighted,3 or the peripheral nervous system (inserted into
peripheral nerve fascicles to trigger the activity of specific axons)
and may also be useful to deliver small molecules or drugs in a
highly localized fashion.43,50-52
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